Compare BELFB & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFB | GRDN |
|---|---|---|
| Founded | 1949 | 2004 |
| Country | United States | United States |
| Employees | 4964 | 3600 |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | BELFB | GRDN |
|---|---|---|
| Price | $195.70 | $37.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $174.25 | $39.00 |
| AVG Volume (30 Days) | 143.7K | ★ 497.2K |
| Earning Date | 04-23-2026 | 03-11-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.74 | N/A |
| Revenue Next Year | $6.34 | $7.14 |
| P/E Ratio | ★ $42.80 | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $58.00 | $19.17 |
| 52 Week High | $248.61 | $38.34 |
| Indicator | BELFB | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 63.13 |
| Support Level | $130.49 | $27.73 |
| Resistance Level | $248.61 | $37.78 |
| Average True Range (ATR) | 11.25 | 1.77 |
| MACD | -0.88 | 0.23 |
| Stochastic Oscillator | 21.88 | 91.88 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.